108 related articles for article (PubMed ID: 9458301)
1. Cytotoxic agents active against mucinous adenocarcinoma of the ovary.
Shimizu Y; Nagata H; Kikuchi Y; Umezawa S; Hasumi K; Yokokura T
Oncol Rep; 1998; 5(1):99-101. PubMed ID: 9458301
[TBL] [Abstract][Full Text] [Related]
2. Activity of cytotoxic agents against clear cell carcinoma of the ovary which is intrinsically platinum-refractory.
Shimizu Y; Nagata H; Umezawa S; Nishida M; Kikuchi Y; Hasumi K; Yokokura T
Oncol Rep; 1997; 4(5):945-8. PubMed ID: 21590172
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N
Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
5. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice].
Matsumoto S; Mashiba H; Okamoto K; Ekimoto H
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1313-20. PubMed ID: 10478185
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
Vassal G; Terrier-Lacombe MJ; Bissery MC; Vénuat AM; Gyergyay F; Bénard J; Morizet J; Boland I; Ardouin P; Bressac-de-Paillerets B; Gouyette A
Br J Cancer; 1996 Aug; 74(4):537-45. PubMed ID: 8761367
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.
Nagai S; Yamauchi M; Satta T; Kodera Y; Kondou K; Akiyaya S; Ito K; Takagi H
J Surg Oncol; 1993 Dec; 54(4):211-5. PubMed ID: 8255079
[TBL] [Abstract][Full Text] [Related]
9. In vitro thermochemotherapy of colon cancer cell lines with irinotecan alone and combined with mitomycin C.
Le Page S; Kwiatkowski F; Paulin C; Mohamed F; Pezet D; Chipponi J; Benhamed M; Gilly FN; Glehen O
Hepatogastroenterology; 2006; 53(71):693-7. PubMed ID: 17086870
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
Allegrini G; Goulette FA; Darnowski JW; Calabresi P
Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
Chen YL; Chueh FS; Yang JS; Hsueh SC; Lu CC; Chiang JH; Lee CS; Lu HF; Chung JG
Environ Toxicol; 2015 Jul; 30(7):803-15. PubMed ID: 24474168
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary.
Takahashi R; Mabuchi S; Kawano M; Sasano T; Matsumoto Y; Kuroda H; Kozasa K; Hashimoto K; Sawada K; Kimura T
PLoS One; 2016; 11(3):e0151050. PubMed ID: 26986199
[TBL] [Abstract][Full Text] [Related]
13. Reversal of CPT-11 resistance of lung cancer cells by adenovirus-mediated gene transfer of the human carboxylesterase cDNA.
Kojima A; Hackett NR; Crystal RG
Cancer Res; 1998 Oct; 58(19):4368-74. PubMed ID: 9766666
[TBL] [Abstract][Full Text] [Related]
14. In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
Yamashita K; Urakami A; Kubozoe T; Ikeda M; Hirabayashi Y; Yamamura M; Iki K; Akiyama T; Matsumoto H; Hirai T; Sadahira Y; Tsunoda T
Int J Clin Oncol; 2005 Oct; 10(5):328-32. PubMed ID: 16247659
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of CPT-11 for gastrointestinal cancer cells cultured on fixed-contact-sensitive plates.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Takiguchi S; Kono A
Anticancer Drugs; 1995 Jun; 6(3):413-8. PubMed ID: 7670139
[TBL] [Abstract][Full Text] [Related]
16. Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo.
Pollack IF; Erff M; Bom D; Burke TG; Strode JT; Curran DP
Cancer Res; 1999 Oct; 59(19):4898-905. PubMed ID: 10519402
[TBL] [Abstract][Full Text] [Related]
17. Effects of CPT-11 in combination with other anti-cancer agents in culture.
Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
[TBL] [Abstract][Full Text] [Related]
18. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
[TBL] [Abstract][Full Text] [Related]
19. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11 (irinotecan).
O'meara AT; Sevin BU
Gynecol Oncol; 1999 Feb; 72(2):143-7. PubMed ID: 10021292
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of treatment of colon, lung and breast human carcinoma xenografts with: doxorubicin, cisplatin, irinotecan or topotecan.
Hardman WE; Moyer MP; Cameron IL
Anticancer Res; 1999; 19(3B):2269-74. PubMed ID: 10472342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
